The role of lymphocytes in allergic disease

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 3, 2000, Pages 399-408

  Romagnani, Sergio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Allergic rhinitis; Allergy; Asthma; Atopy; Chemokines; Cytokines; Hygiene hypothesis; Oligodeoxynucleotides; T(H)1 T(H)2 cells

Indexed keywords

CHEMOKINE; CYTOKINE; EOTAXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC DISEASE; ANTIBODY PRODUCTION; ATOPY; BASOPHIL; CYTOKINE PRODUCTION; EOSINOPHIL; HELPER CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE; MAST CELL; PRIORITY JOURNAL; REVIEW;

EID: 0034065298     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.104575     Document Type: Article

References (115)

1. 1. Ehrlich P. Ueber die specifischen granulationen des Blutes. Arch Anat Physiol Lpz Physiol Abt 1879;3:571.
2. 2. Prausnitz C, Kustner H. Studien uber die Veberempfindlichkeit. Zbl Bakt Abt 1 1921;86:160.
3. 3. Ishizaka K, Ishizaka T. Identification of gamma-E-antibodies as a carrier of reaginic activity. J Immunol 1967;99:1187-98.
4. 4. Johansson SG. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 1967;2:951-3.
5. 5. Coffman RL, Carty J. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma. J Immunol 1986;136:949-54.
6. 6. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-8.
7. 7. Pene J, Rousset F, Briere F, Chretien I, Paliard X, Banchereau J, et al. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol 1988;141:1218-24.
8. 8. Mosmann TR, Cherwinski H, Bond MW, Giedli MA, Coffman RL. Two types of murine T cell clone, I: definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
9. 9. Del Prete GF, De Carli M, Mastromauro C, Biagiotti R, Macchia D, Falagiani P, et al. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-50.
10. 10. Romagnani S. The Th2 hypothesis in allergy - "Eppur si muove!" Allergy Clin Immunol Intern 1998;10:158-65.
11. 11. Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, et al. Evidence for compartmentalization of functional subsets of CD4+ T lymphocytes in atopic patients. J Immunol 1990;144:4651-6.
12. 12. Parronchi P, Macchia D, Piccinni M-P, Biswas P, Simonelli C, Maggi E, et al. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci U S A 1991;88:4538-42.
13. 13. Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw AJ, Corrigan CJ, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
14. 14. van der Heijden FL, Wirenga EA, Bos JD, Kapsenberg ML. High frequency of IL-4-producing CD4+ allergen specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-94.
15. 15. Del Prete GF, De Carli M, D'Elios MM, Maestrelli P, Ricci M, Fabbri L, et al. Allergen exposure induces the activation of allergen-specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders. Eur J Immunol 1993;23:1445-9.
16. 16. Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
17. 17. Varney VA, Hamid Q, Gaga M, Ying S, Jacobson M, Frew AJ, et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
18. 18. McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;15:828-38.
19. 19. Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-g secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;54:4187-94.
20. 20. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin-4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737-47.
21. 21. Cohn L, Tepper JS, Bottomly K. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1 cells. J Immunol 1998;161:3813-6.
22. 22. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, et al. Requirements for allergen-induced airway hyperreactivity in T- and B-deficient mice. Mol Med 1998;4:344-55.
23. 23. Schmitz J, Thiel A, Kuhn R, Rajewsky K, Muller W, Assenmacher M, et al. Induction of interleukin 4 (IL-4) expression In T helper (Th) cells is not dependent on IL-4 from non-T cells. J Exp Med 1994;179:1349-53.
24. 24. Miyata S, Matsuyama T, Kodama T, Nishioka Y, Takeda K, Akira S, et al. STAT6 deficiency in a mouse model of allergen-induced airways inflammation abolishes eosinophilia but induces infiltration of CD8+ T cells. Clin Exp Allergy 1999;29:114-23.
25. 25. Matthaei KI, Foster P, Young IG. The role of interleukin-5 (IL-5) in vivo: studies with IL-5 deficient mice. Mem Inst Oswaldo Cruz 1997;92:63-8.
26. 26. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnomalities and eotaxin production. J Clin Invest 1999;103:779-88.
27. 27. Temann U-A, Geba GP, Rankin JA, Flavell RA. Expression of interleukin-9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia and bronchial hyperresponsiveness. J Exp Med 1998;188:1307-20.
28. 28. Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, DiCosmo B, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin-4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A 1996;93:7821-5.
29. 29. Lee JJ, McGarry MP, Farmer SC, Denzler KL, Larson KA, Carrigan PE, et al. Inlerleukin 5 expression in the lung epithelium of trasgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997;185:2143-56.
30. 30. Elias JA, Zhu Z, Chupp G, Homer RJ. Airway remodeling in asthma. J Clin Invest 1999;104:1001-6.
31. 31. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-57.
32. 32. Finkelman FD, Shea Donobue T, Goldhill J, Sullivan CA, Morris SC, Madden KB, et al. Cytokine regulation of host defense against parasitic gastrointestinal nematodes: lessons from studies with rodent models. Annu Rev Immunol 1997;15: 505-33.
33. 33. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996;383:787-93.
34. 34. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S. Role of type 2 T helper (Th2) cytokines and leukemia inhibitory factor (LIF) produced by decidual T cells in unexplained recurrent abortions. Nat Med 1998;4:1020-4.
35. 35. Galli G, Chantry D, Annunziato F, Romagnani P, Cosmi L, Lazzeri E, et al. MDC production by activated human T cells in vitro and in vivo. Preferential association with the production of type 2 cytokines. Eur J Immunol 2000;30:204-10.
36. 36. Bonecchi R, Sozzani S, Stine JT, Luini W, D'Amico G, Allavena P, et al. Effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood 1998;92:2668-71.
37. 37. Constant SL, Bottomly K. Induction of TH1 and TH2 CD4+ T cell responses: the alternative approaches. Annu Rev Immunol 1997;15:297-322.
38. 38. Lenschovv DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
39. 39. Ohshima Y, Yang LP, Uchiyama T, Tanaka Y, Baum P, Sergerie M, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4 producing effectors. Blood 1998;92:3338-45.
40. 40. Tao X, Constant S, Jorritsma P, Bottomly K. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J Immunol 1997;159:5956-63.
41. 41. Bendelac A, Hunziker R, Lantz O. Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NKL1 T cells. J Exp Med 1996;184:1285-93.
42. 42. Maggi E, Parronchi P, Manetti R, Simonelli C, Piccinni MP, Santoni-Rugiu F, et al. Reciprocal regulatory role of IFN-g and IL-4 on the in vitro development of human Th1 and Th2 cells. J Immunol 1992;148:2142-7.
43. 43. Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, et al. IL-4 and IFN(s) (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 1992;149:2977-82.
44. 44. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, et al. Natural killer cell stimulatory factor (interleukin-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-204.
45. 45. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999;10:127-36.
46. 46. Rogge L, Barberis L, Passini N, Presky DH, Gubler U, Sinigaglia F. Selective expression of an interleukin 12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825-31.
47. 47. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996;380:630-2.
48. 48. Rao A, Luo C, Hogan PG. Transcription factors of the NF-AT family: regulation and function. Annu Rev Immunol 1997;15:707-47.
49. 49. Glimcher LH, Singh H. Transcription factors in lymphocyte development - T and B cells get together. Cell 1999;96:13-23.
50. 50. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997;276:589-92.
51. 51. Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997;16:161-70.
52. 52. Hodge MR, Chun HJ, Rengarajan J, Alt A, Lieberson R, Glimcher LH. NF-AT-driven interleukin-4 transcription potentialed by NIP45. Science 1996;274:1903-5.
53. 53. Yang L, Cohn L, Zhang DH, Homer R, Ray A, Ray P. Essential role of nucler factor kB in the induction of eosinophilia in allergic airway inflammation. J Exp Med 1998;188:1739-50.
54. 54. Siegel MD, Zhang D-H, Ray P, Ray A. Activation of the intereukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 ad CLEO elements. J Biol Chem 1995;270:24548-55.
55. 55. Ho CI, Hodge MR, Rooney JW, Glimcher LH. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996;85:973-83.
56. 56. Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 1997;89:587-96.
57. 57. Szabo SJ, Glimcher LH, Ho I-C. Genes that regulate interleukin-4 expression in T cells. Curr Opin Immunol 1997;9:776-81.
58. 58. Barnes KC, Marsh DG. The genetics and complexity of allergy and asthma. Immunol Today 1998;19:325-31.
59. 59. Piccinni M-P, Mecacci F, Sampognaro S, Manetti R, Parronchi P, Maggi E, et al. Aeroallergen sensitization can occur during fetal life. Int Arch Allergy Immunol 1993;102:301-3.
60. 60. Jones AC, Miles EA, Warner JO, Colwell BM, Bryant TN, Warner JA. Fetal peripheral blood mononuclear cell proliferative responses to mitogenic and allergenic stimuli during gestation. Pediatr Allergy Immunol 1996;7:109-116.
61. 61. Prescott SL, Macaubas C, Holt BJ, Smallacombe TB, Loh R, Sly PD, et al. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J Immunol 1998;160:4730-37.
62. 62. Wegmann TG, Lin H, Guilbert L, Mosmann RT. Bidirectional cytokine onteractions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993;14:353-6.
63. 63. Piccinni MP, Giudizi MG, Biagiotti R, Annunziato F, Manetti R, Giannarini L, et al. Progesterone favors the development of human T helper (Th) cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 clones. J Immunol 1995;155:128-33.
64. 64. Romagnani S. Regulation of the development of type 2 T-helper cells in allergy. Curr Opin Immunol 1994;6:838-46.
65. 65. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-9.
66. 66. von Mutius E, Martinez FD, Fritzsch C, Nicolai T, Reitmeir P, Thiemann HH. Skin test reactivity and number of siblings. BMJ 1994;308:692-5.
67. 67. Shirikawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorders. Science 1997;275:77-9.
68. 68. Matricardi PM, Rosmini F, Ferrigno L, Nisini R, Raoucetta M, Chionne P, et al. Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ 1997;314:999-1003.
69. 69. Tang L, Benjaponpitak S, DeKruyff RH, Umetsu DT. Reduced prevalence of allergic disease in patients with multiple sclerosis is associated with enhanced IL-12 production. J Allergy Clin Immunol 1998;102:428-35.
70. 70. Adams JF, Scholvinck EH, Gie RP, Potter PC, Beyers N, Beyers AD. Decline in total serum IgE after treatment for tuberculosis. Lancet 1999;353:2030-3.
71. 71. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999;353:1485-8.
72. 72. MacLean JA, Sauty A, Luster AD, Drazen JM, De Sanctis GT. Antigen-induced airway hyperresponsiveness, pulmonary eosinophilia, and chemokine expression in B cell-deficient mice. Am J Respir Cell Mol Biol 1999;20:379-87.
73. 73. van de Rijn M, Melhop PD, Judkins A, Rothenberg ME, Luster AD, Oettgen HC. A murine model of allergic rhinitis: studies on the role of IgE in pathogenesis and analysis of the eosinophil influx elicited by allergen and eotaxin. J Allergy Clin Immunol 1998;102:65-74.
74. 74. Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J Clin Invest 1997;99:1329-39.
75. 75. Takeda K, Hamelmann E, Joetham A, Shultz L, Larsen GL, Irvin CG, et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice. J Exp Med 1997;186:449-54.
76. 76. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:1497-504.
77. 77. Brugnolo F, Annunziato F, Sampognaro S, Campi P, Manfredi M, Matucci A, et al. Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J Immunol 1999;163:1053-9.
78. 78. Bochner BS, Schleimer RP. The role of adhesion molecules in human eosinophils and basophils recruitment. J Allergy Clin Immunol 1994;94:427-38.
79. 79. Teran LM. Chemokines and IL-5: major players of eosinophil recruitment in asthma. Clin Exp Allergy 1999;29:287-90.
80. 80. Heath H, Qin S, Rao P, Wu L, LaRosa G, Kassam N, et al. Chemokine receptor usage by human eosinophils: the importance of CCR3 demonstrated using an antagonistic monoclonal antibody. J Clin Invest 1997;99:178-84.
81. 81. Uguccioni M, Mackay CR, Ochensberger B, Loetscher P, Rhis S, LaRosa GJ, et al. High expression of the chemokine receptor CCR3 in human blood basophils: role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest 1997;100:1137-43.
82. 82. Ochi H, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine-mediated comitigenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med 1999;190:267-80.
83. 83. Romagnani P, De Paulis A, Beltrame C, Annunziato F, Dente V, Maggi E, et al. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol 1999;155:1195-204.
84. 84. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 1997;277:2005-7.
85. 85. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler DJ, et al. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma: association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol 1997;27:3507-16.
86. 86. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, et al. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87.
87. 87. Teran LM, Mochizuki M, Bartels J, Valencia EL, Nakajima T, Hirai K, et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 1999;20:777-86.
88. 88. Shinkai A, Yoshisue H, Koike M, Shoji E, Nakagawa S, Saito A, et al. A novel human CC chemokine, eotaxin 3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinpìhils. J Immunol 1999;163:1602-10.
89. 89. Devouassoux G, Metcalfe DD, Prussin C. Eotaxin potentiates antigen-dependent basophil IL-4 production. J Immunol 1999;163:2877-882.
90. 90. Postlethwaite AE, Holness MA, Katai H, Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin. J Clin Invest 1992;90:1479-85.
91. 91. Sempowski GD, Beckmann MP, Derdak S, Phipps RP. Subsets of murine lung fibroblasts express membrane-bound and soluble IL-4 receptors: role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. J Immunol 1994;152:3606-14.
92. 92. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma. J Clin Invest 1998;101:2129-39.
93. 93. Jain-Vora S, Wert SE, Temann U-A, Rankin JA, Whitsett JA. Interleukin-4 alters epithelial cell differentiation and surfactant homeostasis in the postnatal mouse lung. Am J Respir Crit Care Med 1997;17:541-51.
94. 94. Minshall EM, Leung DY, Martin RJ, Song YL, Cameron L, Ernst P, et al. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997;17:326-33.
95. 95. Ohno I, Nitta Y, Yamauchi K, Hoshi H, Honma M, Woolley K, et al. Transforming growth factor-β1 (TGF-β1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Crit Care Med 1996;15:404-9.
96. 96. DiCosmo BF, Geba GP, Picarella D, Elias JA, Rankin JA, Stripp BR, et al. Airway targeted interleukin-6 in trasngenic mice: uncoupling of airway inflammation and bronchial hyperreactivity. J Clin Invest 1994;94:2028-35.
97. 97. Tang W, Geba GP, Zheng T, Ray P, Homer RJ, Kuhn C III, et al. Targeted expression of IL-11 in the murine airways causes airways obstruction, bronchial remodeling and lymphocytic inflammation. J Clin Invest 1996;98:2845-53.
98. 98. Vestergaard C, Yoneyama H, Murai M, Nakamura K, Tamaki K, Terashima Y, et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhbiting atopic dermatitis-like lesions. J Clin Invest 1999;104:1097-105.
99. 99. Parronchi P, Maggi E, Romagnani S. Redirecting Th2 responses in allergy. Curr Topics Microbiol Immunol 1999;238:27-56.
100. 100. Grunewald SM, Werthmann A, Schnarr B, Klein CE, Brocker EB, Mohrs M, et al. An antagonistic IL-4 mutant prevents type 1 allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J Immunol 1998;160:4004-9.
101. 101. Kung TT, Stelts DM, Zurcher JA, Adams GK, Egan RW, Kreutner W, et al. Involvement of IL-5 in a murine model of allergic pulmonary inflammation: prophylactic and theraputic effect of an anti-IL-5 antibody. Am J Respir Cell Mol Biol 1995;13:360-5.
102. 102. Okudaira H, Mori A, Mikami T, Kaminuma O, Ohmura T, Hoshino A, et al. Selective suppression of IL-5 synthesis by OM-01 - pinpoint treatment of atopic diseases by IL-5 gene transcription inhibitor. Int Arch Allergy Immunol 1997;113:331-4.
103. 103. Jardieu P. Anti-IgE therapy. Curr Opin Immunol 1995;7:779-82.
104. 104. Corne J, Djukanovic R, Thomas L, Warner J, Botta L, Grandordy B, et al. The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics. J Clin Invest 1997;99:879-87.
105. 105. Lord CJM, Lamb JR. TH2 cells in allergic inflammation: a target of immunotherapy. Clin Exp Allergy 1996;26:756-65.
106. 106. Tsitoura DC, Verhoef A, Gelder CM, O'Heir R, Lamb JR. Altered T cell ligands derived from a major house dust mite allergen enhance IFN-gamma but not IL-4 production by human CD4+ T cells. J Immunol 1996;157:2160-5.
107. 107. Matsuoka T, Kohrogi H, Ando M, Nishimura Y, Matsushita S. Altered TCR ligands affect antigen-presenting cell responses: up-regulation of IL-12 by an analogue peptide. J Immunol 1996;157:4837-43.
108. 108. Hofstra CL, Van Ark I, Hofman G, Kool M, Nijkamp FP, Van Oosterhout AJ. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J Immunol 1998;161:5054-60.
109. 109. Erb KJ, Holloway JW, Sobeck A, Moll H, Le Gros G. Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guérin suppresses allergen-induced airway eosinophilia. J Exp Med 1998;187:561-9.
110. 110. Hsu CH, Chua KY, Tao MH, Huang SK, Hsieh KH. Inhibition of specific IgE response in vivo by allergen-gene transfer. Int Immunol 1996;8:1405-11.
111. 111. Raz E, Tighe E, Sato Y, Corr M, Dudler JA, Roman M, et al. Preferential induction of aTh1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci U S A 1996;93:5141-5.
112. 112. Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, et al. Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 1998;161:7054-62.
113. 113. Kline JN, Waldschmidt JT, Businga TR, Lemish JE, Weinstock JV, Thorne PS, et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998;160:2555-9.
114. 114. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 1997;186:1623-31.
115. 115. Parronchi P, Brugnolo F, Annunziato F, Manuelli C, Sampognaro S, Mavilia C, et al. Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into type 1 T helper (Th1) effectors. J Immunol 1999;163:5946-53.